✦ LIBER ✦

Vasoconstrictor Therapy for the Hepatorenal Syndrome

✍ Scribed by Joseph K. Lim; Roberto J. Groszmann

Book ID: 119760340
Publisher: Elsevier Science
Year: 2008
Tongue: English
Weight: 371 KB
Volume: 134
Category: Article
ISSN: 0016-5085
DOI: 10.1053/j.gastro.2008.03.034

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Vasoconstrictor therapy for patients wit

Vasoconstrictor therapy for patients with cirrhosis with ascites but without hepatorenal syndrome

✍ Georgios N. Kalambokis; Epameinondas V. Tsianos 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 47 KB

Therapy for hepatorenal syndrome

✍ Florence Wong; Laurence Blendis 📂 Article 📅 1998 🏛 Elsevier Science 🌐 English ⚖ 26 KB

More therapy for hepatorenal syndrome

✍ Laurence Blendis; Florence Wong 📂 Article 📅 1999 🏛 Elsevier Science 🌐 English ⚖ 35 KB

Current Therapies for Hepatorenal Syndro

Current Therapies for Hepatorenal Syndrome

✍ Bonder, Alan; Botero, Maria L.; Cardenas, Andres 📂 Article 📅 2014 🏛 Current Science Inc. 🌐 English ⚖ 221 KB

Systematic review of randomized trials o

Systematic review of randomized trials on vasoconstrictor drugs for hepatorenal syndrome

✍ Lise L. Gluud; Kurt Christensen; Erik Christensen; Aleksander Krag 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 357 KB

Vasoconstrictor drugs may improve renal function in hepatorenal syndrome (HRS), but the effect on mortality has not been established. We therefore performed a systematic review of randomized trials on vasoconstrictor drugs for type 1 or type 2 HRS. Mortality was the primary outcome measure. Eligible

Meta-analysis: terlipressin therapy for

Meta-analysis: terlipressin therapy for the hepatorenal syndrome

✍ F. FABRIZI; V. DIXIT; P. MARTIN 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 524 KB